title: [DSM-5: important changes in the field of addictive diseases].
abstract: There are two major changes in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) concerning the field of addiction. Firstly, the previous distinction between abuse and dependence has been abolished and both disorders are now subsumed under the category addiction and related disorders. Secondly, pathological gambling has now been included in the section of addiction with slight changes in diagnostic criteria. Both changes have major implications for the definition and conceptualization of what we call a psychiatric "disease" or "disorder", which have also been addressed in the introductory statement of DSM-5. Concerning the category of abuse that is now part of substance use disorders, there is a concern that a well-defined disorder ("dependence") is now mixed with a less well-defined syndrome ("abuse"). The inclusion of non-substance, behavioral addictions poses the danger of pathologizing a wide range of human behavior in future revisions of the classification. Both concerns are further addressed in this article.
authors.affiliation: Klinik für Psychiatrie und Psychotherapie, Charité - Universitätsmedizin Berlin, Campus Mitte, Charitéplatz 1, 10117, Berlin, Deutschland, andreas.heinz@charite.de.
authors.forename: A
authors.initials: A
authors.lastname: Heinz
authors.forename: E
authors.initials: E
authors.lastname: Friedel
mesh_terms: D039721:Diagnostic and Statistical Manual of Mental Disorders; D017408:Guidelines as Topic; D006801:Humans; D008370:Manuals as Topic / Q000592:standards*; D011569:Psychiatric Status Rating Scales / Q000592:standards*; D011570:Psychiatry / Q000592:standards*; D019966:Substance-Related Disorders / Q000145:classification* / Q000175:diagnosis* / Q000523:psychology; D014481:United States
references.citation: Nat Rev Neurosci. 2011 Jun 02;12(7):400-13
references.pmid: 21633380
references.citation: J Med Ethics. 2014 Apr;40(4):286-7
references.pmid: 23468510
references.citation: Neuroimage. 2008 Feb 15;39(4):1559-69
references.pmid: 18096409
references.citation: Nervenarzt. 2013 May;84(5):548-56
references.pmid: 23604411
references.citation: Pharmacopsychiatry. 2009 May;42 Suppl 1:S95-S101
references.pmid: 19434561
references.citation: PLoS One. 2011;6(9):e24992
references.pmid: 21980372
references.citation: Addiction. 2010 Feb;105(2):240-54
references.pmid: 20078482
references.citation: Neurosci Biobehav Rev. 2014 Jan;38:1-16
references.pmid: 24211373
references.citation: Mol Psychiatry. 2004 Jun;9(6):557-69
references.pmid: 15098002
references.citation: J Neurosci. 2013 Mar 6;33(10):4527-35
references.pmid: 23467368
references.citation: Br J Addict. 1990 Apr;85(4):447-61
references.pmid: 2189511
references.citation: Addict Biol. 2013 Jan;18(1):121-33
references.pmid: 22574861
references.citation: Am J Psychiatry. 2013 Aug;170(8):834-51
references.pmid: 23903334
references.citation: Drug Alcohol Rev. 2007 Jan;26(1):25-31
references.pmid: 17364833
references.citation: Am J Psychiatry. 2004 Oct;161(10):1783-9
references.pmid: 15465974
references.citation: J Addict Dis. 1996;15(4):55-71
references.pmid: 8943582
references.citation: Pharmacol Biochem Behav. 1996 Oct;55(2):297-302
references.pmid: 8951968
references.citation: Pharmacopsychiatry. 2002 Jul;35(4):127-34
references.pmid: 12163982
references.citation: Arch Gen Psychiatry. 2012 Aug;69(8):842-52
references.pmid: 22868938
references.citation: Br Med J. 1976 May 1;1(6017):1058-61
references.pmid: 773501